H. Devaud

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line

M. Mouret-Reynier, P. Dubray-Longeras, I. van Praagh, 2015, Oncology.

Pancreatic intubation facilitated by methylene blue injection decreases the risk for postpapillectomy acute pancreatitis

M. Dapoigny, M. Goutte, J. Joubert, 2014, European journal of gastroenterology & hepatology.

Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program

M. Mouret-Reynier, P. Dubray-Longeras, F. Kwiatkowski, 2019, Supportive Care in Cancer.

401PEVEROLIMUS PLUS HORMONOTHERAPY (HT) INDUCES SURVIVAL GAIN IN LATE METASTATIC BREAST CANCER (MBC) AFTER PROGRESSION: COULD THIS LINE BE BETTER THAN A LATE NEW CHEMOTHERAPY (CT) LINE?

M. Mouret-Reynier, P. Dubray-Longeras, I. van Praagh, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Panitumumab in combination with FEC 100 (5-fluorouracil, epidoxorubicin, cyclophosphamide) followed by docetaxel (T) in patients with operable, triple-negative breast cancer (TNBC): Preliminary results of a multicenter neoadjuvant pilot phase II study.

B. Weber, T. Petit, O. Trédan, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.